Regulation of intestinal cancer stem cells

Cancer Letters

Volumn 338, Issue 1, 2013, Pages 120-126

  Ashley, Neil ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

BMP; Colon; Differentiation; Hypoxia; Myofibroblasts; Notch; Regulation; Stem cells; Wnt

Indexed keywords

BMI1 PROTEIN; BONE MORPHOGENETIC PROTEIN 4; CELL MARKER; EPHRIN RECEPTOR B2; MICRORNA; MICRORNA 144; MICRORNA 145; MICRORNA 17 5P; MICRORNA 17 92; NOTCH1 RECEPTOR; PROTEIN ASCL2; PROTEIN LGR5; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CDX1; UNCLASSIFIED DRUG; WNT PROTEIN;

ASCL2 GENE; CANCER PROGNOSIS; CANCER STEM CELL; CELL DIFFERENTIATION; CELL HYPOXIA; CELL PROLIFERATION; CLONOGENESIS; COLORECTAL CANCER; DNA METHYLATION; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMAN; INTESTINE CANCER; INTRACELLULAR SIGNALING; LGR5 GENE; MYOFIBROBLAST; NONHUMAN; NOTCH SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SHORT SURVEY; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; WNT SIGNALING PATHWAY;

EID: 84882906229     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.04.016     Document Type: Review

References (100)

1. Creamer B., Shorter R.G., Bamforth J., turnover The The turnover and shedding of epithelial cells. I. The turnover in the gastro-intestinal tract. Gut 1961, 2:110-118.
2. Sangiorgi E., Capecchi M.R. Bmi1 is expressed in vivo in intestinal stem cells. Nat. Genet. 2008, 40:915-920.
3. Montgomery R.K., Carlone D.L., Richmond C.A., Farilla L., Kranendonk M.E., Henderson D.E., Baffour-Awuah N.Y., Ambruzs D.M., Fogli L.K., Algra S., Breault D.T. Mouse telomerase reverse transcriptase (mTert) expression marks slowly cycling intestinal stem cells. Proc. Natl. Acad. Sci. USA 2011, 108:179-184.
4. Takeda N., Jain R., LeBoeuf M.R., Wang Q., Lu M.M., Epstein J.A. Interconversion between intestinal stem cell populations in distinct niches. Science 2011, 334:1420-1424.
5. Barker N., van Es J.H., Kuipers J., Kujala P., van den Born M., Cozijnsen M., Haegebarth A., Korving J., Begthel H., Peters P.J., Clevers H. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007, 449:1003-1007.
6. Snippert H.J., van Es J.H., van den Born M., Begthel H., Stange D.E., Barker N., Clevers H. Prominin-1/CD133 marks stem cells and early progenitors in mouse small intestine. Gastroenterology 2009, 136:2187-2194. e2181.
7. Zhu L., Gibson P., Currle D.S., Tong Y., Richardson R.J., Bayazitov I.T., Poppleton H., Zakharenko S., Ellison D.W., Gilbertson R.J. Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 2009, 457:603-607.
8. Tian H., Biehs B., Warming S., Leong K.G., Rangell L., Klein O.D., de Sauvage F.J. A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable. Nature 2011, 478:255-259.
9. Yan K.S., Chia L.A., Li X., Ootani A., Su J., Lee J.Y., Su N., Luo Y., Heilshorn S.C., Amieva M.R., Sangiorgi E., Capecchi M.R., Kuo C.J. The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations. Proc. Natl. Acad. Sci. USA 2011.
10. Barker N., Ridgway R.A., van Es J.H., van de Wetering M., Begthel H., van den Born M., Danenberg E., Clarke A.R., Sansom O.J., Clevers H. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009, 457:608-611.
11. Clevers H. The cancer stem cell: premises, promises and challenges. Nat. Med. 2011, 17:313-319.
12. Kern D.H., Campbell M.A., Cochran A.J., Burk M.W., Morton D.L. Cloning of human solid tumors in soft agar. Int. J. Cancer 1982, 30:725-729.
13. Dexter D.L., Spremulli E.N., Fligiel Z., Barbosa J.A., Vogel R., VanVoorhees A., Calabresi P. Heterogeneity of cancer cells from a single human colon carcinoma. Am. J. Med. 1981, 71:949-956.
14. Laboisse C.L., Augeron C., Potet F. Growth and differentiation of human gastrointestinal adenocarcinoma stem cells in soft agarose. Cancer Res. 1981, 41:310-315.
15. Vermeulen L., Todaro M., de Sousa Mello F., Sprick M.R., Kemper K., Perez Alea M., Richel D.J., Stassi G., Medema J.P. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc. Natl. Acad. Sci. USA 2008, 105:13427-13432.
16. Yeung T.M., Gandhi S.C., Wilding J.L., Muschel R., Bodmer W.F. Cancer stem cells from colorectal cancer-derived cell lines. Proc. Natl. Acad. Sci. USA 2010, 107:3722-3727.
17. Ricci-Vitiani L., Lombardi D.G., Pilozzi E., Biffoni M., Todaro M., Peschle C., De Maria R. Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445:111-115.
18. Dieter S.M., Ball C.R., Hoffmann C.M., Nowrouzi A., Herbst F., Zavidij O., Abel U., Arens A., Weichert W., Brand K., Koch M., Weitz J., Schmidt M., von Kalle C., Glimm H. Distinct types of tumor-initiating cells form human colon cancer tumors and metastases. Cell Stem Cell 2011, 9:357-365.
19. Dalerba P., Kalisky T., Sahoo D., Rajendran P.S., Rothenberg M.E., Leyrat A.A., Sim S., Okamoto J., Johnston D.M., Qian D., Zabala M., Bueno J., Neff N.F., Wang J., Shelton A.A., Visser B., Hisamori S., Shimono Y., van de Wetering M., Clevers H., Clarke M.F., Quake S.R. Single-cell dissection of transcriptional heterogeneity in human colon tumors. Nat. Biotechnol. 2011, 29:1120-1127.
20. Kirkland S.C. Clonal origin of columnar, mucous, and endocrine cell lineages in human colorectal epithelium. Cancer 1988, 61:1359-1363.
21. Richman P.I., Bodmer W.F. Control of differentiation in human colorectal carcinoma cell lines: epithelial-mesenchymal interactions. J. Pathol. 1988, 156:197-211.
22. Yokoyama S., Takifuji K., Hotta T., Matsuda K., Tominaga T., Oku Y., Nasu T., Tamura K., Ieda J., Yamaue H. Moderately differentiated colorectal adenocarcinoma as a lymph node metastatic phenotype: comparison with well differentiated counterparts. BMC Surg. 2010, 10:8.
23. Ruschoff J., Dietmaier W., Luttges J., Seitz G., Bocker T., Zirngibl H., Schlegel J., Schackert H.K., Jauch K.W., Hofstaedter F. Poorly differentiated colonic adenocarcinoma, medullary type: clinical, phenotypic, and molecular characteristics. Am. J. Pathol. 1997, 150:1815-1825.
24. Kazama Y., Watanabe T., Kanazawa T., Tanaka J., Tanaka T., Nagawa H. Microsatellite instability in poorly differentiated adenocarcinomas of the colon and rectum: relationship to clinicopathological features. J. Clin. Pathol. 2007, 60:701-704.
25. Merlos-Suarez A., Barriga F.M., Jung P., Iglesias M., Cespedes M.V., Rossell D., Sevillano M., Hernando-Momblona X., da Silva-Diz V., Munoz P., Clevers H., Sancho E., Mangues R., Batlle E. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell 2011, 8:511-524.
26. Johnston M.D., Maini P.K., Jonathan Chapman S., Edwards C.M., Bodmer W.F. On the proportion of cancer stem cells in a tumour. J. Theor. Biol. 2010, 266:708-711.
27. Dean M., Fojo T., Bates S. Tumour stem cells and drug resistance. Nat. Rev. Cancer 2005, 5:275-284.
28. Vaish M. Mismatch repair deficiencies transforming stem cells into cancer stem cells and therapeutic implications. Mol. Cancer 2007, 6:26.
29. Todaro M., Alea M.P., Di Stefano A.B., Cammareri P., Vermeulen L., Iovino F., Tripodo C., Russo A., Gulotta G., Medema J.P., Stassi G. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 2007, 1:389-402.
30. Emmink B.L., Van Houdt W.J., Vries R.G., Hoogwater F.J., Govaert K.M., Verheem A., Nijkamp M.W., Steller E.J., Jimenez C.R., Clevers H., Borel Rinkes I.H., Kranenburg O. Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan. Gastroenterology 2011, 141:269-278.
31. Pang R., Law W.L., Chu A.C., Poon J.T., Lam C.S., Chow A.K., Ng L., Cheung L.W., Lan X.R., Lan H.Y., Tan V.P., Yau T.C., Poon R.T., Wong B.C. A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. Cell Stem Cell 2010, 6:603-615.
32. de Sousa E.M.F., Colak S., Buikhuisen J., Koster J., Cameron K., de Jong J.H., Tuynman J.B., Prasetyanti P.R., Fessler E., van den Bergh S.P., Rodermond H., Dekker E., van der Loos C.M., Pals S.T., van de Vijver M.J., Versteeg R., Richel D.J., Vermeulen L., Medema J.P. Methylation of cancer-stem-cell-associated Wnt target genes predicts poor prognosis in colorectal cancer patients. Cell Stem Cell 2011, 9:476-485.
33. Pinto D., Gregorieff A., Begthel H., Clevers H. Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes Dev. 2003, 17:1709-1713.
34. Vermeulen L., De Sousa E.M.F., van der Heijden M., Cameron K., de Jong J.H., Borovski T., Tuynman J.B., Todaro M., Merz C., Rodermond H., Sprick M.R., Kemper K., Richel D.J., Stassi G., Medema J.P. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat. Cell Biol. 2010, 12:468-476.
35. Korinek V., Barker N., Moerer P., van Donselaar E., Huls G., Peters P.J., Clevers H. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat. Genet. 1998, 19:379-383.
36. Ireland H., Kemp R., Houghton C., Howard L., Clarke A.R., Sansom O.J., Winton D.J. Inducible Cre-mediated control of gene expression in the murine gastrointestinal tract: effect of loss of beta-catenin. Gastroenterology 2004, 126:1236-1246.
37. Kuhnert F., Davis C.R., Wang H.T., Chu P., Lee M., Yuan J., Nusse R., Kuo C.J. Essential requirement for Wnt signaling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf-1. Proc. Natl. Acad. Sci. USA 2004, 101:266-271.
38. Kim K.A., Kakitani M., Zhao J., Oshima T., Tang T., Binnerts M., Liu Y., Boyle B., Park E., Emtage P., Funk W.D., Tomizuka K. Mitogenic influence of human R-spondin1 on the intestinal epithelium. Science 2005, 309:1256-1259.
39. Kosinski C., Li V.S., Chan A.S., Zhang J., Ho C., Tsui W.Y., Chan T.L., Mifflin R.C., Powell D.W., Yuen S.T., Leung S.Y., Chen X. Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors. Proc. Natl. Acad. Sci. USA 2007, 104:15418-15423.
40. Batlle E., Henderson J.T., Beghtel H., van den Born M.M., Sancho E., Huls G., Meeldijk J., Robertson J., van de Wetering M., Pawson T., Clevers H. Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell 2002, 111:251-263.
41. Fre S., Pallavi S.K., Huyghe M., Lae M., Janssen K.P., Robine S., Artavanis-Tsakonas S., Louvard D. Notch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestine. Proc. Natl. Acad. Sci. USA 2009, 106:6309-6314.
42. Wang Y., Giel-Moloney M., Rindi G., Leiter A.B. Enteroendocrine precursors differentiate independently of Wnt and form serotonin expressing adenomas in response to active beta-catenin. Proc. Natl. Acad. Sci. USA 2007, 104:11328-11333.
43. Mori-Akiyama Y., van den Born M., van Es J.H., Hamilton S.R., Adams H.P., Zhang J., Clevers H., de Crombrugghe B. SOX9 is required for the differentiation of paneth cells in the intestinal epithelium. Gastroenterology 2007, 133:539-546.
44. Bastide P., Darido C., Pannequin J., Kist R., Robine S., Marty-Double C., Bibeau F., Scherer G., Joubert D., Hollande F., Blache P., Jay P. Sox9 regulates cell proliferation and is required for Paneth cell differentiation in the intestinal epithelium. J. Cell Biol. 2007, 178:635-648.
45. Gregorieff A., Pinto D., Begthel H., Destree O., Kielman M., Clevers H. Expression pattern of Wnt signaling components in the adult intestine. Gastroenterology 2005, 129:626-638.
46. Davies P.S., Dismuke A.D., Powell A.E., Carroll K.H., Wong M.H. Wnt-reporter expression pattern in the mouse intestine during homeostasis. BMC Gastroenterol. 2008, 8:57.
47. Sato T., Vries R.G., Snippert H.J., van de Wetering M., Barker N., Stange D.E., van Es J.H., Abo A., Kujala P., Peters P.J., Clevers H. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 2009, 459:262-265.
48. de Lau W., Barker N., Low T.Y., Koo B.K., Li V.S., Teunissen H., Kujala P., Haegebarth A., Peters P.J., van de Wetering M., Stange D.E., van Es J.E., Guardavaccaro D., Schasfoort R.B., Mohri Y., Nishimori K., Mohammed S., Heck A.J., Clevers H. Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature 2011, 476:293-297.
49. Carmon K.S., Gong X., Lin Q., Thomas A., Liu Q. R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/beta-catenin signaling. Proc. Natl. Acad. Sci. USA 2011, 108:11452-11457.
50. Glinka A., Dolde C., Kirsch N., Huang Y.L., Kazanskaya O., Ingelfinger D., Boutros M., Cruciat C.M., Niehrs C. LGR4 and LGR5 are R-spondin receptors mediating Wnt/beta-catenin and Wnt/PCP signalling. EMBO Rep. 2011, 12:1055-1061.
51. Walker F., Zhang H.H., Odorizzi A., Burgess A.W. LGR5 is a negative regulator of tumourigenicity, antagonizes Wnt signalling and regulates cell adhesion in colorectal cancer cell lines. PLoS ONE 2011, 6:e22733.
52. Garcia M.I., Ghiani M., Lefort A., Libert F., Strollo S., Vassart G. LGR5 deficiency deregulates Wnt signaling and leads to precocious Paneth cell differentiation in the fetal intestine. Dev. Biol. 2009, 331:58-67.
53. Kleist B., Xu L., Li G., Kersten C. Expression of the adult intestinal stem cell marker Lgr5 in the metastatic cascade of colorectal cancer. Int. J. Clin. Exp. Pathol. 2011, 4:327-335.
54. van der Flier L.G., Haegebarth A., Stange D.E., van de Wetering M., Clevers H. OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells. Gastroenterology 2009, 137:15-17.
55. Cheasley D., Pereira L., Lightowler S., Vincan E., Malaterre J., Ramsay R.G. Myb controls intestinal stem cell genes and self-renewal. Stem Cells 2011, 29:2042-2050.
56. Takahashi H., Ishii H., Nishida N., Takemasa I., Mizushima T., Ikeda M., Yokobori T., Mimori K., Yamamoto H., Sekimoto M., Doki Y., Mori M. Significance of Lgr5(+ve) cancer stem cells in the colon and rectum. Ann. Surg. Oncol. 2011, 18:1166-1174.
57. van der Flier L.G., van Gijn M.E., Hatzis P., Kujala P., Haegebarth A., Stange D.E., Begthel H., van den Born M., Guryev V., Oving I., van Es J.H., Barker N., Peters P.J., van de Wetering M., Clevers H. Transcription factor achaete scute-like 2 controls intestinal stem cell fate. Cell 2009, 136:903-912.
58. Jubb A.M., Hoeflich K.P., Haverty P.M., Wang J., Koeppen H. Ascl2 and 11p15.5 amplification in colorectal cancer. Gut 2011, 60:1606-1607. (author reply 1607).
59. Reed K.R., Tunster S.J., Young M., Carrico A., John R.M., Clarke A.R. Entopic overexpression of Ascl2 does not accelerate tumourigenesis in ApcMin mice. Gut 2011.
60. Jung P., Sato T., Merlos-Suarez A., Barriga F.M., Iglesias M., Rossell D., Auer H., Gallardo M., Blasco M.A., Sancho E., Clevers H., Batlle E. Isolation and in vitro expansion of human colonic stem cells. Nat. Med. 2011, 17:1225-1227.
61. Widschwendter M., Fiegl H., Egle D., Mueller-Holzner E., Spizzo G., Marth C., Weisenberger D.J., Campan M., Young J., Jacobs I., Laird P.W. Epigenetic stem cell signature in cancer. Nat. Genet. 2007, 39:157-158.
62. Yu T., Chen X., Zhang W., Colon D., Shi J., Napier D., Rychahou P., Lu W., Lee E.Y., Weiss H.L., Evers B.M., Liu C. Regulation of the potential marker for intestinal cells, bmi1, by beta-catenin and the zinc finger protein KLF4: implications for colon cancer. J. Biol. Chem. 2012, 287:3760-3768.
63. Fre S., Huyghe M., Mourikis P., Robine S., Louvard D., Artavanis-Tsakonas S. Notch signals control the fate of immature progenitor cells in the intestine. Nature 2005, 435:964-968.
64. Miyamoto S., Rosenberg D.W. Role of Notch signaling in colon homeostasis and carcinogenesis. Cancer Sci. 2011, 102:1938-1942.
65. Shin H.M., Minter L.M., Cho O.H., Gottipati S., Fauq A.H., Golde T.E., Sonenshein G.E., Osborne B.A. Notch1 augments NF-kappaB activity by facilitating its nuclear retention. EMBO J. 2006, 25:129-138.
66. Sander G.R., Powell B.C. Expression of notch receptors and ligands in the adult gut. J. Histochem. Cytochem. 2004, 52:509-516.
67. Pellegrinet L., Rodilla V., Liu Z., Chen S., Koch U., Espinosa L., Kaestner K.H., Kopan R., Lewis J., Radtke F. Dll1- and dll4-mediated notch signaling are required for homeostasis of intestinal stem cells. Gastroenterology 2011, 140:1230-1240. e1231-1237.
68. van Es J.H., van Gijn M.E., Riccio O., van den Born M., Vooijs M., Begthel H., Cozijnsen M., Robine S., Winton D.J., Radtke F., Clevers H. Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 2005, 435:959-963.
69. Yang Q., Bermingham N.A., Finegold M.J., Zoghbi H.Y. Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science 2001, 294:2155-2158.
70. Anderson E.C., Wong M.H. Caught in the Akt: regulation of Wnt signaling in the intestine. Gastroenterology 2010, 139:718-722.
71. Katoh M. Notch ligand, JAG1, is evolutionarily conserved target of canonical WNT signaling pathway in progenitor cells. Int. J. Mol. Med. 2006, 17:681-685.
72. Katoh M. WNT antagonist, DKK2, is a Notch signaling target in intestinal stem cells: augmentation of a negative regulation system for canonical WNT signaling pathway by the Notch-DKK2 signaling loop in primates. Int. J. Mol. Med. 2007, 19:197-201.
73. Zagouras P., Stifani S., Blaumueller C.M., Carcangiu M.L., Artavanis-Tsakonas S. Alterations in Notch signaling in neoplastic lesions of the human cervix. Proc. Natl. Acad. Sci. USA 1995, 92:6414-6418.
74. Li Y., Burns J.A., Cheney C.A., Zhang N., Vitelli S., Wang F., Bett A., Chastain M., Audoly L.P., Zhang Z.Q. Distinct expression profiles of Notch-1 protein in human solid tumors: Implications for development of targeted therapeutic monoclonal antibodies. Biologics 2010, 4:163-171.
75. Nakakura E.K., Sriuranpong V.R., Kunnimalaiyaan M., Hsiao E.C., Schuebel K.E., Borges M.W., Jin N., Collins B.J., Nelkin B.D., Chen H., Ball D.W. Regulation of neuroendocrine differentiation in gastrointestinal carcinoid tumor cells by notch signaling. J. Clin. Endocrinol. Metab. 2005, 90:4350-4356.
76. Sikandar S.S., Pate K.T., Anderson S., Dizon D., Edwards R.A., Waterman M.L., Lipkin S.M. NOTCH signaling is required for formation and self-renewal of tumor-initiating cells and for repression of secretory cell differentiation in colon cancer. Cancer Res. 2010, 70:1469-1478.
77. Yeung T.M., Gandhi S.C., Bodmer W.F. Hypoxia and lineage specification of cell line-derived colorectal cancer stem cells. Proc. Nat. Acad. Sci. USA 2011, 108:4382-4387.
78. Zhang Y., Li B., Ji Z.Z., Zheng P.S. Notch1 regulates the growth of human colon cancers. Cancer 2010, 116:5207-5218.
79. Geiszt M., Lekstrom K., Brenner S., Hewitt S.M., Dana R., Malech H.L., Leto T.L. NAD(P)H oxidase 1, a product of differentiated colon epithelial cells, can partially replace glycoprotein 91(phox) in the regulated production of superoxide by phagocytes. J. Immunol. 2003, 171:299-306.
80. Laurent E., Mccoy J.W., Macina R.A., Liu W.H., Cheng G.J., Robine S., Papkoff J., Lambeth J.D. Nox1 is over-expressed in human colon cancers and correlates with activating mutations in K-Ras. Int. J. Cancer 2008, 123:100-107.
81. He X.C., Zhang J., Tong W.G., Tawfik O., Ross J., Scoville D.H., Tian Q., Zeng X., He X., Wiedemann L.M., Mishina Y., Li L. BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling. Nat. Genet. 2004, 36:1117-1121.
82. Lombardo Y., Scopelliti A., Cammareri P., Todaro M., Iovino F., Ricci-Vitiani L., Gulotta G., Dieli F., de Maria R., Stassi G. Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice. Gastroenterology 2011, 140:297-309.
83. Monzo M., Navarro A., Bandres E., Artells R., Moreno I., Gel B., Ibeas R., Moreno J., Martinez F., Diaz T., Martinez A., Balague O., Garcia-Foncillas J. Overlapping expression of microRNAs in human embryonic colon and colorectal cancer. Cell Res. 2008, 18:823-833.
84. Bitarte N., Bandres E., Boni V., Zarate R., Rodriguez J., Gonzalez-Huarriz M., Lopez I., Javier Sola J., Alonso M.M., Fortes P., Garcia-Foncillas J. MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells. Stem cells 2011, 29:1661-1671.
85. Yu Y., Kanwar S.S., Patel B.B., Oh P.S., Nautiyal J., Sarkar F.H., Majumdar A.P. MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFbetaR2) in colon cancer cells. Carcinogenesis 2012, 33:68-76.
86. Richman P., Bodmer W. Control of differentiation in human colorectal carcinoma cell lines: epithelial-mesenchymal interactions. J. Pathol. 1988, 156:197-211.
87. Richman P., Tilly R., Jass J., Bodmer W. Colonic pericrypt sheath cells: characterisation of cell type with new monoclonal antibody. J. Clin. Pathol. 1987, 40:593-600.
88. Powell D.W., Adegboyega P.A., Di Mari J.F., Mifflin R.C. Epithelial cells and their neighbors I. Role of intestinal myofibroblasts in development, repair, and cancer. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 289:G2-7.
89. Sato T., van Es J.H., Snippert H.J., Stange D.E., Vries R.G., van den Born M., Barker N., Shroyer N.F., van de Wetering M., Clevers H. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 2011, 469:415-418.
90. Pinchuk I.V., Beswick E.J., Saada J.I., Boya G., Schmitt D., Raju G.S., Brenmoehl J., Rogler G., Reyes V.E., Powell D.W. Human colonic myofibroblasts promote expansion of CD4+ CD25high Foxp3+ regulatory T cells. Gastroenterology 2011, 140:2019-2030.
91. Andoh A., Bamba S., Brittan M., Fujiyama Y., Wright N.A. Role of intestinal subepithelial myofibroblasts in inflammation and regenerative response in the gut. Pharmacol. Ther. 2007, 114:94-106.
92. Chakrabarty S., Fan D., Varani J. Modulation of differentiation and proliferation in human colon carcinoma cells by transforming growth factor beta 1 and beta 2. Int. J. Cancer. J. Int. du Cancer 1990, 46:493-499.
93. McKaig B.C., Makh S.S., Hawkey C.J., Podolsky D.K., Mahida Y.R. Normal human colonic subepithelial myofibroblasts enhance epithelial migration (restitution) via TGF-beta3. Am. J. Physiol. 1999, 276:G1087-1093.
94. Webber J., Steadman R., Mason M.D., Tabi Z., Clayton A. Cancer exosomes trigger fibroblast to myofibroblast differentiation. Cancer Res. 2010, 70:9621-9630.
95. Lewis M.P., Lygoe K.A., Nystrom M.L., Anderson W.P., Speight P.M., Marshall J.F., Thomas G.J. Tumour-derived TGF-beta1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells. Br. J. Cancer 2004, 90:822-832.
96. Pignatelli M., Bodmer W.F. Integrin-receptor-mediated differentiation and growth inhibition are enhanced by transforming growth factor-beta in colorectal tumour cells grown in collagen gel. Int. J. Cancer 1989, 44:518-523.
97. Kirkland S.C., Ying H. Alpha2beta1 integrin regulates lineage commitment in multipotent human colorectal cancer cells. J. Biol. Chem. 2008, 283:27612-27619.
98. Keith B., Simon M.C. Hypoxia-inducible factors, stem cells, and cancer. Cell 2007, 129:465-472.
99. Mazumdar J., O'Brien W.T., Johnson R.S., LaManna J.C., Chavez J.C., Klein P.S., Simon M.C. O2 regulates stem cells through Wnt/beta-catenin signalling. Nat. Cell Biol. 2010, 12:1007-1013.
100. Mathieu J., Zhang Z., Zhou W., Wang A.J., Heddleston J.M., Pinna C.M., Hubaud A., Stadler B., Choi M., Bar M., Tewari M., Liu A., Vessella R., Rostomily R., Born D., Horwitz M., Ware C., Blau C.A., Cleary M.A., Rich J.N., Ruohola-Baker H. HIF induces human embryonic stem cell markers in cancer cells. Cancer Res. 2011, 71:4640-4652.